Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,449 | 458 | 98.4% |
| Education | $138.53 | 9 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,006 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,932 | 83 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,114 | 67 | $0 (2024) |
| Lilly USA, LLC | $823.02 | 49 | $0 (2024) |
| Amgen Inc. | $426.28 | 21 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $366.80 | 22 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $305.05 | 21 | $0 (2022) |
| Merck Sharp & Dohme LLC | $285.95 | 19 | $0 (2024) |
| PFIZER INC. | $219.64 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $212.02 | 13 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,184 | 47 | AstraZeneca Pharmaceuticals LP ($377.52) |
| 2023 | $1,049 | 50 | AstraZeneca Pharmaceuticals LP ($278.84) |
| 2022 | $1,126 | 67 | Novo Nordisk Inc ($236.43) |
| 2021 | $1,219 | 79 | Kowa Pharmaceuticals America, Inc. ($200.38) |
| 2020 | $1,119 | 67 | AstraZeneca Pharmaceuticals LP ($235.68) |
| 2019 | $1,105 | 58 | AstraZeneca Pharmaceuticals LP ($378.58) |
| 2018 | $872.14 | 45 | Novo Nordisk Inc ($251.05) |
| 2017 | $913.18 | 54 | Novo Nordisk Inc ($506.47) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: VACCINE | ||||||
| 10/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Cardiovascular | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Respiratory | ||||||
| 06/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 359 | 776 | $137,925 | $43,645 |
| 2022 | 4 | 391 | 827 | $145,295 | $34,709 |
| 2021 | 3 | 406 | 901 | $132,946 | $54,604 |
| 2020 | 8 | 563 | 898 | $110,850 | $36,082 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 479 | $94,643 | $29,413 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 242 | $33,950 | $9,555 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $7,698 | $4,166 | 54.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 21 | $1,635 | $511.18 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 573 | $110,187 | $24,052 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 223 | $29,515 | $9,099 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $4,075 | $1,063 | 26.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 13 | $1,517 | $495.42 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 245 | 664 | $106,500 | $43,354 | 40.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 148 | 224 | $23,503 | $9,557 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $2,943 | $1,693 | 57.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 181 | 325 | $52,492 | $16,663 | 31.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 200 | 361 | $37,846 | $11,936 | 31.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 106 | 132 | $7,255 | $2,144 | 29.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 20 | 23 | $5,037 | $2,079 | 41.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 15 | 15 | $3,396 | $1,711 | 50.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 14 | $2,045 | $665.32 | 32.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 17 | 17 | $1,495 | $465.35 | 31.1% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 11 | 11 | $1,284 | $417.40 | 32.5% |
About Dr. Marcus Nichols, DO
Dr. Marcus Nichols, DO is a Pediatrics healthcare provider based in Marietta, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750350559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Nichols, DO has received a total of $8,588 in payments from pharmaceutical and medical device companies, with $1,184 received in 2024. These payments were reported across 467 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($8,449).
As a Medicare-enrolled provider, Nichols has provided services to 1,719 Medicare beneficiaries, totaling 3,402 services with total Medicare billing of $169,039. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Marietta, OH
- Active Since 03/15/2006
- Last Updated 06/20/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750350559
Products in Payments
- FARXIGA (Drug) $1,361
- JARDIANCE (Drug) $731.64
- Ozempic (Drug) $700.74
- Livalo (Drug) $366.80
- AIRSUPRA (Drug) $346.69
- Rybelsus (Drug) $329.15
- TRINTELLIX (Drug) $257.87
- EMGALITY (Drug) $256.01
- TRULICITY (Drug) $248.16
- Victoza (Drug) $241.56
- EVENITY (Biological) $216.79
- Vascepa (Drug) $212.02
- Xultophy 100/3.6 (Drug) $206.81
- Tresiba (Drug) $188.08
- ELIQUIS (Drug) $185.28
- STIOLTO RESPIMAT (Drug) $173.09
- SPIRIVA RESPIMAT (Drug) $158.34
- Aimovig (Biological) $154.11
- Wegovy (Drug) $153.63
- TRADJENTA (Drug) $143.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Marietta
Mr. Forrest Cantrell, M.d, M.D
Pediatrics — Payments: $86,144
Dr. Daniel Heine, M.d, M.D
Pediatrics — Payments: $4,473
Dr. Rhonda Thompson, O.d, O.D
Pediatrics — Payments: $3,648
Dr. Jose Rodriguez-Torres, Md, MD
Pediatrics — Payments: $3,520
Dr. Daniel Saade, Md, MD
Pediatrics — Payments: $2,902
Bakari Morgan, Md, MD
Pediatrics — Payments: $2,780